Skip to content
Tuesday, August 9, 2022
Latest:
  • Genome-wide study reveals new susceptibility genetic variants for lung cancer
  • Don’t get into a tizzy if your water is fizzy
  • The path forward: a more inclusive healthcare system
  • Raising awareness of spina bifida
  • Fertility Series: Advanced maternal age

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

mTOR inhibitors

From The Labs 

New evidence supports a cancer-promoting role for enzyme MAPK6

December 6, 2021December 6, 2021cancer growth, MAPK4, MAPK6, mTOR inhibitors, Research

The findings suggest that therapies that interfere with MAPK6 activity may offer an effective cancer treatment approach.

Read more

From the Labs Video of the Month

From The Labs Image of the Month From the Labs: A beating developing mouse heart.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951